Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Mirabel Meds vs Onyx Weight Loss

Mirabel Meds
Graded #397

Lower grade

vs+1.2999999999999972
Onyx Weight Loss
Graded #358

Higher grade

The verdict

Onyx Weight Loss takes it — 58.8/100 to 57.5/100, but only just.

Onyx Weight Loss grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Onyx Weight Loss is a nurse-practitioner-led telehealth clinic based in Mooresville, NC, offering GLP-1 and GLP-1/GIP weight-loss medications alongside peptides and HRT across 8 states. Mirabel Meds is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMirabel Meds +2
45
43
Dose & formulationOnyx Weight Loss +24
40
64
Clinical oversightMirabel Meds +4
79
75
Labs & monitoringOnyx Weight Loss +9
54
63
FulfillmentMirabel Meds +30
83
53
Contract termsEven
55
55
Mirabel Meds · left barOnyx Weight Loss · right bar

The numbers

MetricMirabel MedsOnyx Weight Loss
WeighScore57.5/10058.8/100
GradeCC
Scorecard rank#397#358
SemaglutideNot disclosed$228/mo (starting dose, compounded)
TirzepatideNot disclosed$280/mo (starting dose, compounded)
CoverageAll 50 states8 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Mirabel Meds

Graded #397 · C

Strengths

  • LegitScript certified with board-certified Internal Medicine physician oversight
  • Compounded semaglutide, tirzepatide, and GLP-1 microdose injection options
  • White-glove concierge — direct provider messaging, no automated bots
  • Cold-chain temperature-controlled delivery to all 50 states
  • Monthly clinical reviews and dose adjustments included with every plan

Where it loses points

  • Pricing not publicly disclosed — requires a consultation to receive a quote
  • Compounded medications are not FDA-approved individual drugs
  • No named pharmacy partner disclosed on public pages
  • Labs not mentioned on any public page — baseline bloodwork protocol unknown
  • Concierge positioning suggests premium pricing above market average
Onyx Weight Loss

Graded #358 · C

Strengths

  • Competitive entry pricing: semaglutide from $228/mo and tirzepatide from $280/mo with medication + supplies included
  • Nurse-practitioner-led care: founder Tasha Vangile FNP-C (20+ years) and Stephanie Robison APRN-CNP (27 years experience)
  • Low-cost $99/mo GLP-1 microdosing option for patients who prefer a gradual titration start
  • Strive Pharmacy partnership implies compounded 503A-quality supply chain from a known pharmacy
  • Multi-modal clinic: GLP-1 + peptides + HRT + nutrition coaching available under one provider team

Where it loses points

  • Only 8 states (NC, CO, ME, VT, VA, IA, NH, PA) — excludes the majority of the US
  • No LegitScript certification; credentialing evidence limited to local 2025 Best of Iredell award
  • Specific drug names (semaglutide/tirzepatide) never stated on website; compounded status inferred, not disclosed
  • Labs not included or mentioned; no baseline bloodwork protocol published
  • Pricing shown as 'Starting at' with no dose-escalation tier pricing disclosed publicly

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard